Randomized controlled trial of biofeedback, sham feedback, and standard therapy for dyssynergic defecation
- PMID: 17368232
- DOI: 10.1016/j.cgh.2006.12.023
Randomized controlled trial of biofeedback, sham feedback, and standard therapy for dyssynergic defecation
Abstract
Background & aims: Constipation is a common disorder, and current treatments are generally unsatisfactory. Biofeedback might help patients with constipation and dyssynergic defecation, but its efficacy is unproven, and whether improvements are due to operant conditioning or personal attention is unknown.
Methods: In a prospective randomized trial, we investigated the efficacy of biofeedback (manometric-assisted anal relaxation, muscle coordination, and simulated defecation training; biofeedback) with either sham feedback therapy (sham) or standard therapy (diet, exercise, laxatives; standard) in 77 subjects (69 women) with chronic constipation and dyssynergic defecation. At baseline and after treatment (3 months), physiologic changes were assessed by anorectal manometry, balloon expulsion, and colonic transit study and symptomatic changes and stool characteristics by visual analog scale and prospective stool diary. Primary outcome measures (intention-to-treat analysis) included presence of dyssynergia, balloon expulsion time, number of complete spontaneous bowel movements, and global bowel satisfaction.
Results: Subjects in the biofeedback group were more likely to correct dyssynergia (P < .0001), improve defecation index (P < .0001), and decrease balloon expulsion time (P = .02) than other groups. Colonic transit improved after biofeedback or standard (P = .01) but not after sham. In the biofeedback group, the number of complete spontaneous bowel movements increased (P < .02) and was higher (P < .05) than in other groups, and use of digital maneuvers decreased (P = .03). Global bowel satisfaction was higher (P = .04) in the biofeedback than sham group.
Conclusions: Biofeedback improves constipation and physiologic characteristics of bowel function in patients with dyssynergia. This effect is mediated by modifying physiologic behavior and colorectal function. Biofeedback is the preferred treatment for constipated patients with dyssynergia.
Comment in
-
Randomized controlled trial of biofeedback.Clin Gastroenterol Hepatol. 2007 Sep;5(9):1119; author reply 1119. doi: 10.1016/j.cgh.2007.05.027. Clin Gastroenterol Hepatol. 2007. PMID: 17825773 No abstract available.
-
Is biofeedback therapy an effective treatment for dyssynergic defecation?Nat Clin Pract Gastroenterol Hepatol. 2008 Feb;5(2):74-5. doi: 10.1038/ncpgasthep1032. Epub 2007 Dec 18. Nat Clin Pract Gastroenterol Hepatol. 2008. PMID: 18087300 No abstract available.
Similar articles
-
Obstructive defecation: a failure of rectoanal coordination.Am J Gastroenterol. 1998 Jul;93(7):1042-50. doi: 10.1111/j.1572-0241.1998.00326.x. Am J Gastroenterol. 1998. PMID: 9672327
-
Outcome of biofeedback therapy in dyssynergic defecation patients with and without irritable bowel syndrome.J Clin Gastroenterol. 2011 Aug;45(7):593-8. doi: 10.1097/MCG.0b013e31820c6001. J Clin Gastroenterol. 2011. PMID: 21346602
-
Randomized, controlled trial shows biofeedback to be superior to alternative treatments for patients with pelvic floor dyssynergia-type constipation.Dis Colon Rectum. 2007 Apr;50(4):428-41. doi: 10.1007/s10350-006-0814-9. Dis Colon Rectum. 2007. PMID: 17294322 Clinical Trial.
-
Constipation: Pathophysiology and Current Therapeutic Approaches.Handb Exp Pharmacol. 2017;239:59-74. doi: 10.1007/164_2016_111. Handb Exp Pharmacol. 2017. PMID: 28185025 Review.
-
Biofeedback therapy for dyssynergic defecation.World J Gastroenterol. 2006 Nov 28;12(44):7069-74. doi: 10.3748/wjg.v12.i44.7069. World J Gastroenterol. 2006. PMID: 17131466 Free PMC article. Review.
Cited by
-
Biofeedback therapy in constipation and fecal incontinence.J Neurogastroenterol Motil. 2010 Apr;16(2):110-2. doi: 10.5056/jnm.2010.16.2.110. Epub 2010 Apr 27. J Neurogastroenterol Motil. 2010. PMID: 20535340 Free PMC article. No abstract available.
-
Pelvic floor rehabilitation for defecation disorders.Tech Coloproctol. 2019 Feb;23(2):101-115. doi: 10.1007/s10151-018-1921-z. Epub 2019 Jan 10. Tech Coloproctol. 2019. PMID: 30631977 Review.
-
Effects of Alfuzosin, an α1-Adrenergic Antagonist, on Anal Pressures and Bowel Habits in Women With and Without Defecatory Disorders.Clin Gastroenterol Hepatol. 2019 May;17(6):1138-1147.e3. doi: 10.1016/j.cgh.2018.08.036. Epub 2018 Aug 18. Clin Gastroenterol Hepatol. 2019. PMID: 30130627 Free PMC article. Clinical Trial.
-
High resolution and high definition anorectal manometry and pressure topography: diagnostic advance or a new kid on the block?Curr Gastroenterol Rep. 2013 Dec;15(12):360. doi: 10.1007/s11894-013-0360-2. Curr Gastroenterol Rep. 2013. PMID: 24271955 Review.
-
The Use of Standardized Questions in Identifying Patients with Dyssynergic Defecation.J Can Assoc Gastroenterol. 2018 Mar 30;1(2):60-66. doi: 10.1093/jcag/gwy010. eCollection 2018 Jun. J Can Assoc Gastroenterol. 2018. PMID: 31294401 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical